We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
The review of the safety of isotretinoin has concluded.
Topical steroid products are safe and highly effective treatments for the management of a wide range of inflammatory skin diseases but have important risks, especially with prolonged use at high potency. In the coming months, as a result of regulatory...
Public Assessment Report (PAR) reviewing available safety data for topical steroid withdrawal reactions, which have been associated with topical corticosteroids.
Information for healthcare professionals to protect the public from pressure ulcers (bed sores).
Product Safety Report for Anise Shealight Fading Cream Face & Body (Batch AOS18, 18/06/2023) presenting a serious chemical risk.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Take care when using creams to treat dry skin conditions as they can easily dry onto clothing, bedding and bandages making them more flammable.
Sets out the immediate actions government will be taking in the short term in response to the recommendations made in the independent Pregnancy Loss Review.
Guidance for Police and Crime Commissioners on how to access the income loss recovery scheme for lost sales, fees and charges as a result of COVID-19.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Product Safety Report for RODIS Creme Skin Light presenting a serious chemical risk due to the presence of the skin sensitiser hydroquinone.
Product Safety Report for Skin Gard Lightening Lotion presenting a serious chemical risk.
Evidence reviews conducted by the Clinical and Public Health Response Evidence Review team and the Science Evidence Review team within UKHSA.
Guidance for local authorities on how to access the local government income compensation scheme for lost sales, fees and charges as a result of COVID-19.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).